Picture of InnovAge Holding logo

INNV InnovAge Holding Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Annual income statement for InnovAge Holding, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue567638699688764
Cost of Revenue
Gross Profit141174135101132
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses516665703737787
Operating Profit50.9-26.8-4.41-49.4-23.2
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes35.6-35-7.24-50.8-21.8
Provision for Income Taxes
Net Income After Taxes25.8-44.7-7.96-43.6-23.2
Minority Interest
Net Income Before Extraordinary Items
Net Income26.3-44-6.52-40.7-21.3
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income26.3-44-6.52-40.7-21.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.2380.0760.054-0.168-0.082
Dividends per Share